Heroin is associated almost axiomatically with injecting. The development of tolerance and dependence presumably
induces the user to move to a more efficient administration ritual. The low prevalence of injecting drug use among
heroin users in The Netherlands --unique compared to other countries in Europe and the rest of the Western world-is, however, at odds with this assumption. Nevertheless, research into this atypical situation has not been undertaken
before. Only few studies have addressed the issue, but none in depth. Table 4.1 summarizes some relevant results
from Dutch studies that presented findings on the prevalence of drug administration rituals. Most of these studies
were conducted by Korf and colleagues. The table provides a few first impressions regarding the prevalence of
injecting drug use in some cities and towns in The Netherlands and confirms the atypical Dutch situation.


4.2.1 Matching the Samples: Dilemmas and Choices
Secondary analysis of already existing data has both advantages and disadvantages. Obviously, secondary analysis
is inexpensive and --perhaps even more important-- it limits the burden on respondents. Disadvantageous is, however,
that the data were collected with some specific aim, thereby often not, or only partially addressing the explicit
questions to be answered in the secondary analysis. In the presented secondary analysis some difficult choices were
made in order to make both samples and data-sets comparable and usable to address the aforementioned questions.
(table 4.2) First of all the data-sets have been reduced to autochtonic subjects. The reason for this is twofold. The
Amsterdam AIDS-Cohort Sample (AACS) includes many foreigners; only 71% of the original sample (n=520) has a
Dutch nationality. In the Rotterdam Methadone- Intake Sample (RIVIIS) the majority of the clients (n = 1123) are
either autochtonic Dutch (64%) or Surinamese (17%). Since most Surinamese drug users do not inject, it was
decided to limit both samples to autochtonic, white, Dutch subjects. Secondly, since the RMIS consists of subjects
seeking methadone treatment it should be of no surprise that 99% report opiates to be their drug of first choice. Again
for the sake of comparability and clarity, both samples have been restricted to opiate using subjects. For the AACS
this implies that heroin, methadone or other opiate use at least two days a week was taken as an inclusion criterion.
The combined inclusion criteria resulted in matched samples of Autochtonic, White, Dutch Opiate Dependent
Subjects, with a sample-size for the RMIS of 711 subjects and for the AACS of 282 subjects.
Regarding the route of administration, the following points must be stressed. Both the AACS and the RMIS are selfreported data and therefore subject to the usual limitations. While in Amsterdam specific questions about (first)
injection practices were asked, in Rotterdam subjects were merely asked if they injected their drugs. The Rotterdam
data are therefore more likely a representation of the subjects self-definition as either an IDU or a chaser --they
contain no information on life-time prevalence of injecting or (single) exceptions. In the AACS current injecting has been defined as 'having injected at least once
during the half year prior to interview. However, of the total sample 87.2% has ever injected, while 60% of the subjects
defined as current non-IDUs have injected at least once in their career.
* Four cases were collected in 1991.
In analyzing the data and testing the hypothesis both univariate and multivariate statistical techniques have been
applied, using SPSS/PC. First, current administration ritual (CAR) has been related to several relevant variables. For
dichotomous variables, e.g., sex and cocaine use, Ch i2 -statistics have been computed, while for interval variables,
such as the year of heroin career onset, t-tests were performed. Although the relative number of current IDUs in the
RMIS and the AACS differed, the factors correlating with injecting were identical. Therefore, the univariate correlates
of injecting are presented for both samples combined. Second, all tested variables which related to CAR were
consequently entered into a multivariate discriminant analysis. To test the hypothesis, a hierarchical procedure was
selected in which - after forced entry of all other variables - the year of onset of the heroin career was entered last,
thereby testing whether this variable contributed significantly to the discriminant function (i.c., in terms of reducing
Wilks's Lambda, which is "a statistic which takes into consideration both the differences between groups and the
cohesiveness or homogeneity within groups`) after the discriminative value of the other variables had been assessed. Results of the
discriminant analyses, presented separately for the RMIS and AACS, are summarized in terms of (1) standardized
canonical discriminant function coefficients (which give a measure of the relative and standardized contribution of the
specific variable with respect to the discriminant function - and thus, in this case, the discriminative value of that
variable in discriminating current IDUs from current non-IDUs), and (2) the classification results (i.e., by comparing the
classification as IDU or non-IDU based on the discriminant function with the actual CAR). Unless otherwise indicated,
in the following (non-)IDU refers to current (non-) IDU.
Table 4.3 summarizes demographic and drug use variables of both the selected and unselected versions of the
Rotterdam Methadone Intake Sample (RMIS) and the Amsterdam AIDS-Cohort Sample (AACS). The selected RMIS
subjects are more likely to be female, younger, injecting, using pills and less likely to use cocaine. This is probably
the result of the exclusion of allochtonic users, as these are more often male, older, cocaine users and smokers,
while they use pills less frequently." 5 This may likewise account for the higher prevalence of injecting and pill use
among the selected AACS subjects and partly for the lower proportion of females in this sample. The latter difference
is, however, also a result of the exclusion of users with a foreign nationality. Study subjects of the AACS enrolled
through one of the seven methadone clinics (one of these takes only sex workers or non-resident drug users as
clients) of the Drugs Department of the Municipal Health Service in Amsterdam or through the separate STD clinic for
addicted sex workers." Compared to the total client population of these methadone clinics the AACS contained more
women. 12 A relatively large proportion of these were foreign sex workers.
The exclusion of foreign users in Amsterdam may also explain for the different gender ratios of the two samples, as
those of the total methadone client populations are in both cities remarkable similar.` 12 The differences between the
samples in age and year of onset of the heroin career may well be due to geographical diffusion. The prevalence of
current injecting in the AACS is twice as high as in the RMIS (68% versus 32%). This difference might be explained
by the different contexts in which the data have been gathered. In Rotterdam the subjects entered a methadone
(maintenance) program, for which they were routinely questioned. However, the Amsterdam subjects made a
deliberate choice to have themselves screened for HIVinfection. Since the possibility to become HIV infected is
significantly related to injecting drugs (as opposed to non-injecting modes of drug administration), it is not odd that
injecting drug users (IDUs) are over-represented in the AACS.13

4.3.1 Year of Onset of the Heroin Career and Current Injecting
In both samples a relationship has been found between, the year in which the heroin career commenced and whether
or not injecting was the current self-administration ritual. Amsterdam IDUs on the average started using heroin on a
regular basis in the beginning of 1977, while non-IDUs used opiates regularly two years later.* Similarly, Rotterdam
IDUs are addicted since the middle of 1978 as compared to non-IDUs who became addicted in the early 1980s. **This
relationship is presented graphically in figure 4.1. It can be seen that opiate users, that started their drug career as
early as 1970 or before, are in minority non-IDUs (45% for RMIS and 26% for AACS). This percentage rises steadily -via 71% and 39% for those starting in the early 1980s--- to 88% and 75% for (respectively, RMIS and AACS) subjects
starting their drug career as late as 1989 to 1991.


The conventional view on heroin use assumes an (inescapable) sequence to more efficient self-administration rituals
as a result of the progressive proces of addiction. From this viewpoint the preceding results may be questioned,
because the year of onset correlates with the length of the career. It could be argued that the non-IDUs have not
reached a point in their career at which injecting becomes opportune or necessary. Therefore, for IDUs the time
between first use of opiates and first injection
was calculated, and compared to the length of the heroin career of non-IDUs.* As the data on first injection was not
available for the RMIS, this analysis was limited to the AACS.

--- Resp.: 10.5 years, std.dev. - 5.1 and 8.8 years, std.dev. = 5.3; t - -2.6, cif - 278, p < .05
... In 35 cases first injecting supposedly preceded regular use of heroin (or other opiates). Some of these individuals
may have injected heroin on an occasional basis prior to regularly using the drug. Others probably injected other
drugs, such as amphetamine or opium, before heroin use. Some discrepancy may have resulted from errors of
interviewee's memory or interpretation, the interviewer, and/or further data processing (recording, entry, or coding).
Given these explanations, it was decided to equate these cases with subjects, who reported first injection and first
heroin/opiate use in the same year (time lapse - 0 year). Excluding these cases did not really influence the results of
the analysis.
within two and 77% within four years (mean= 2.1, median= 1, mode= 0). In contrast, four out of five non-IDUs have
been using opiates for at least tour years and half of them have a career length of more than eight years. Thus,
comparing the length of the heroin using career of non-IDUs to the transition time of IDUs, it can be concluded that
non-IDUs have been long enough at risk to initiate a regular injection pattern.
1. Katz E, Levin ML, Hamilton H: Traditions of research on the diffusions of innovation. American
Sociological Review 1963; 28: 237-252.
2. Parker H, Newcombe R, Bakx K: The new heroin users: prevalence and characteristics in Wirral,
Merseyside. British Journal of Addiction 1987, 82: 147-157,
3. Bindels P, Steinbusch M, Tiggelman A, Vernooy R: Onderzoeksverslag 1 Methadonteam Utrecht.
Utrecht: Consultatiebureau Alcohol en Drugs Utrecht, 1981.
4. Korf DJ: Heroinetoerisme 11: Resultaten van een veldonderzoek onder 382 buitenlandse dage
lijkse opiaatgebruikers in Amsterdam. Amsterdam: ISG, Universiteit van Amsterdam, 1987.
5. Korf DJ, Hoogenhout HPH: Zoden aan de dijk: Heroinegebruikers en hun ervaringen met en
waardering van de Amsterdamse drugshulpverlening. Amsterdam: Instituut voor Sociale Geografie, Universiteit van
Amsterdam, 1990.
6. Korf DJ, Mann 1, Aalderen H van: Drugs op het platteland. Assen/Maastricht: Van Gorcum,
1989.
7. Korf DJ, Aalderen H van, Hogenhout HPH, Sandwijk JP: Gooise Geneugten: Legaal en illegaal
drugsgebruik (in de regio). Amsterdam: SPCP Amsterdam, 1990.
8. Hes J, Korf DJ, Buning E, Elorche M: Bekijk het Een follow-up onderzoek naar audiovisuele
en andere AIDS-voorlichting bij drugskliėnten van de Amsterdamse GG&GD. Amsterdam: Amsterdamse Werkgroep
Aids en Drugs, 1991.
9. Klecka WR: Discriminant analysis. Beverly Hilis/London: Sage University Paper, # 19, 1980: 54. 10, Toet J: Het
RODIS nader bekeken: Cocainegebruikers, Marokkanen en nieuwkomers in de
Rotterdamse drugshulpverlening rapport 87. Rotterdam: GGID-Rotterdam e.o., Aldeling Epidemiology, 1990.
11. Hartgers C, Hoek JAR van den, Krijnen P, Brussei GHA, Coutinho RA: Changes over time in
heroin and cocaine use among injecting drug users in Amsterdam, The Netherlands, 1985-1989. British Journal of
Addiction 1991; 86: 1091-1097.
12. Reijneveld SA: Methadonverstrekking in Amsterdam in 1990: Jaaroverzicht van de Centrale
Methadon Registratie. Amsterdam: GG&GID Amsterdam, Stafbureau Epidemiologie en Documentatie, 1991.
13. Hartgers C, Santen GW van, Haastrecht HJA van, Hoek JAR van den, Akker R van den,
Coutinho RA: De HIV-preva)entie onder druggebruikers die methadon verstrekt krijgen bij de drugsafdeling van de
GG&GD te Amsterdam. T Soc Gezondheicisz 1992; 70: 275-279.